DISCIPLINED GROWTH INVESTORS INC /MN - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
DISCIPLINED GROWTH INVESTORS INC /MN ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$31,651,924
-32.1%
1,973,312
-1.8%
0.75%
-28.4%
Q2 2023$46,587,210
-4.0%
2,009,802
-3.8%
1.05%
-15.6%
Q1 2023$48,522,452
+47.2%
2,088,784
-8.1%
1.24%
+47.3%
Q4 2022$32,973,162
-24.2%
2,272,444
-0.3%
0.84%
-30.0%
Q3 2022$43,474,000
+25.9%
2,278,490
+19.9%
1.21%
+29.9%
Q2 2022$34,537,000
-26.9%
1,900,787
+1.4%
0.93%
-9.4%
Q1 2022$47,237,000
-7.3%
1,874,478
+1.5%
1.02%
-0.1%
Q4 2021$50,963,000
-16.3%
1,846,490
-2.0%
1.03%
-15.0%
Q3 2021$60,868,000
+5.9%
1,885,032
+0.3%
1.21%
+10.0%
Q2 2021$57,454,000
+3.2%
1,878,821
+2.8%
1.10%
-2.7%
Q1 2021$55,667,000
+35.5%
1,828,131
-12.0%
1.13%
+42.2%
Q4 2020$41,094,000
+47.7%
2,078,075
-2.6%
0.79%
+21.8%
Q3 2020$27,826,000
+11.8%
2,133,877
-2.7%
0.65%
+8.0%
Q2 2020$24,882,000
-42.6%
2,194,204
-27.6%
0.60%
-39.1%
Q1 2020$43,350,000
-44.3%
3,029,345
+6.0%
0.99%
-22.8%
Q4 2019$77,824,000
-2.3%
2,858,015
+2.7%
1.28%
-13.0%
Q3 2019$79,649,000
+5.9%
2,782,027
+2.8%
1.47%
+5.4%
Q2 2019$75,211,000
-20.6%
2,707,364
-5.1%
1.40%
-15.7%
Q1 2019$94,689,000
+143.1%
2,852,064
+112.8%
1.66%
+106.7%
Q4 2018$38,958,000
-37.6%
1,340,133
-1.3%
0.80%
-23.2%
Q3 2018$62,438,000
+28.4%
1,357,351
+4.3%
1.05%
+16.5%
Q2 2018$48,638,000
+24.6%
1,301,525
-1.5%
0.90%
+17.1%
Q1 2018$39,041,000
-15.7%
1,321,171
-2.0%
0.77%
-15.9%
Q4 2017$46,291,000
-5.1%
1,347,828
-0.0%
0.91%
-10.8%
Q3 2017$48,775,000
+38.6%
1,348,107
-1.0%
1.02%
+39.2%
Q2 2017$35,182,000
+34.8%
1,361,532
+0.2%
0.73%
+26.3%
Q1 2017$26,097,000
+14.4%
1,359,197
-0.7%
0.58%
+11.5%
Q4 2016$22,815,000
-18.0%
1,368,635
+1.2%
0.52%
-21.2%
Q3 2016$27,832,000
-33.0%
1,352,357
-0.4%
0.66%
-36.7%
Q2 2016$41,530,000
-15.9%
1,357,182
+2.9%
1.04%
-16.9%
Q1 2016$49,388,000
-15.2%
1,319,482
-2.2%
1.26%
-14.3%
Q4 2015$58,215,000
+12.6%
1,348,807
-2.2%
1.47%
+10.7%
Q3 2015$51,682,000
+11.5%
1,378,932
+1.2%
1.32%
+18.3%
Q2 2015$46,336,000
-3.4%
1,363,232
+0.6%
1.12%
-0.9%
Q1 2015$47,957,000
+63.5%
1,354,707
+57.3%
1.13%
+62.0%
Q4 2014$29,340,000
-12.3%
861,407
-0.7%
0.70%
-18.9%
Q3 2014$33,453,000
+2.3%
867,332
+3.2%
0.86%
+0.6%
Q2 2014$32,706,000
+10.4%
840,332
-3.0%
0.85%
+13.4%
Q1 2014$29,626,000
+70.5%
866,512
+4.6%
0.75%
+66.2%
Q4 2013$17,372,000
-7.0%
828,037
+4.2%
0.45%
-16.9%
Q3 2013$18,680,000
-10.2%
794,880
+2.6%
0.54%
-19.0%
Q2 2013$20,811,000774,5200.67%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders